MicroPort (00853) surged nearly 5% again, and as of press time, the stock was up 4.53% to HK$15, with a trading volume of HK$86.87 million.

On the news front, MicroPort recently announced the restructuring of its heart rhythm management business. Subsidiary MicroPort CardioFlow plans to merge with CRM Cayman. Upon completion of the merger, CRM Cayman will become a wholly-owned subsidiary of MicroPort CardioFlow.

Market participants previously pointed out that this merger aims to resolve the pressure from the "compliance listing" performance targets in the heart rhythm business. JPMorgan indicated that the successful completion of the transaction will help eliminate major uncertainties that have been persistently troubling the company.

Bank of America Securities issued a research report stating that the company's previous introduction of Shanghai Industrial, which has state-owned enterprise background, as a strategic shareholder will support both financial and business development. The bank expects that through cost control and disposal of non-core assets, the company is likely to achieve profitability in the first half of 2026.

Additionally, the rapid growth of overseas business can also diversify domestic market risks and provide long-term growth visibility.